Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 34 studies | 32% ± 12% | |
pericyte | 19 studies | 23% ± 5% | |
smooth muscle cell | 18 studies | 23% ± 6% | |
connective tissue cell | 13 studies | 30% ± 13% | |
myofibroblast cell | 10 studies | 23% ± 5% | |
adipocyte | 10 studies | 39% ± 11% | |
astrocyte | 8 studies | 31% ± 14% | |
endothelial cell | 6 studies | 29% ± 7% | |
retinal pigment epithelial cell | 4 studies | 51% ± 20% | |
mesothelial cell | 3 studies | 26% ± 8% | |
muscle cell | 3 studies | 38% ± 20% | |
GABAergic neuron | 3 studies | 22% ± 7% | |
chondrocyte | 3 studies | 38% ± 15% | |
endothelial cell of lymphatic vessel | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 11320.55 | 455 / 459 | 95% | 17.12 | 1058 / 1118 |
prostate | 94% | 6851.83 | 230 / 245 | 91% | 12.45 | 457 / 502 |
lung | 99% | 6369.02 | 572 / 578 | 82% | 10.38 | 951 / 1155 |
adrenal gland | 100% | 26898.70 | 258 / 258 | 76% | 18.82 | 175 / 230 |
skin | 81% | 10169.71 | 1468 / 1809 | 93% | 37.76 | 439 / 472 |
esophagus | 88% | 12376.51 | 1271 / 1445 | 82% | 12.39 | 150 / 183 |
ovary | 100% | 10160.19 | 180 / 180 | 68% | 6.86 | 294 / 430 |
thymus | 96% | 6088.15 | 630 / 653 | 67% | 6.54 | 408 / 605 |
intestine | 95% | 16303.12 | 916 / 966 | 66% | 8.16 | 347 / 527 |
bladder | 100% | 10143.10 | 21 / 21 | 54% | 6.18 | 270 / 504 |
uterus | 99% | 10411.83 | 169 / 170 | 54% | 11.06 | 247 / 459 |
stomach | 71% | 7437.29 | 254 / 359 | 76% | 13.33 | 217 / 286 |
brain | 32% | 1071.50 | 856 / 2642 | 93% | 20.69 | 655 / 705 |
adipose | 100% | 16056.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 14385.44 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 24.67 | 79 / 80 |
pancreas | 3% | 71.01 | 9 / 328 | 89% | 16.88 | 159 / 178 |
kidney | 31% | 1135.12 | 28 / 89 | 59% | 7.76 | 531 / 901 |
heart | 84% | 5071.00 | 727 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 62% | 4.50 | 18 / 29 |
tonsil | 0% | 0 | 0 / 0 | 47% | 3.60 | 21 / 45 |
liver | 1% | 21.85 | 2 / 226 | 24% | 1.69 | 96 / 406 |
muscle | 10% | 291.82 | 78 / 803 | 0% | 0 | 0 / 0 |
spleen | 9% | 236.39 | 21 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 24.52 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035994 | Biological process | response to muscle stretch |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
GO_0090091 | Biological process | positive regulation of extracellular matrix disassembly |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_1904754 | Biological process | positive regulation of vascular associated smooth muscle cell migration |
GO_0007165 | Biological process | signal transduction |
GO_0010763 | Biological process | positive regulation of fibroblast migration |
GO_0035988 | Biological process | chondrocyte proliferation |
GO_0007275 | Biological process | multicellular organism development |
GO_0038063 | Biological process | collagen-activated tyrosine kinase receptor signaling pathway |
GO_0030500 | Biological process | regulation of bone mineralization |
GO_0007155 | Biological process | cell adhesion |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0010715 | Biological process | regulation of extracellular matrix disassembly |
GO_0045860 | Biological process | positive regulation of protein kinase activity |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0032967 | Biological process | positive regulation of collagen biosynthetic process |
GO_0031214 | Biological process | biomineral tissue development |
GO_0034103 | Biological process | regulation of tissue remodeling |
GO_1901299 | Biological process | negative regulation of hydrogen peroxide-mediated programmed cell death |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0030199 | Biological process | collagen fibril organization |
GO_0001503 | Biological process | ossification |
GO_1904899 | Biological process | positive regulation of hepatic stellate cell proliferation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_2000491 | Biological process | positive regulation of hepatic stellate cell activation |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0003416 | Biological process | endochondral bone growth |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_1904385 | Biological process | cellular response to angiotensin |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0038062 | Molecular function | protein tyrosine kinase collagen receptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005518 | Molecular function | collagen binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DDR2 |
Protein name | Discoidin domain receptor tyrosine kinase 2 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) |
Synonyms | TYRO10 TKT NTRKR3 |
Description | FUNCTION: Tyrosine kinase involved in the regulation of tissues remodeling . It functions as a cell surface receptor for fibrillar collagen and regulates cell differentiation, remodeling of the extracellular matrix, cell migration and cell proliferation. Required for normal bone development. Regulates osteoblast differentiation and chondrocyte maturation via a signaling pathway that involves MAP kinases and leads to the activation of the transcription factor RUNX2. Regulates remodeling of the extracellular matrix by up-regulation of the collagenases MMP1, MMP2 and MMP13, and thereby facilitates cell migration and tumor cell invasion. Promotes fibroblast migration and proliferation, and thereby contributes to cutaneous wound healing. . |
Accessions | ENST00000367922.7 Q5T244 ENST00000671979.1 ENST00000415555.5 A0A5F9ZI27 ENST00000367921.8 ENST00000446985.6 Q16832 |